{
    "2021-08-30": [
        [
            {
                "time": "",
                "original_text": "和讯曝财报|上半年营收超千亿同比增长20.73% 上海医药10款在研创新药取得阶段性进展",
                "features": {
                    "keywords": [
                        "上海医药",
                        "营收",
                        "同比增长",
                        "创新药",
                        "阶段性进展"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "上海医药：中期盈利35.68亿人民币，同比增长46.05%",
                "features": {
                    "keywords": [
                        "上海医药",
                        "中期盈利",
                        "同比增长"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "上海医药：上半年净利润同比增长46.05%",
                "features": {
                    "keywords": [
                        "上海医药",
                        "净利润",
                        "同比增长"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "上海医药(601607.SH)半年度净利润35.68亿元 同比增长46.05%",
                "features": {
                    "keywords": [
                        "上海医药",
                        "半年度净利润",
                        "同比增长"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "创新药管线加速扩张 上海医药(601607.SH)上半年归母净利同比增46.05%至35.68亿元",
                "features": {
                    "keywords": [
                        "创新药",
                        "上海医药",
                        "归母净利",
                        "同比增长"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}